ロード中...
Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants
BACKGROUND: Although mother-to-child human immunodeficiency virus (HIV) transmission has dramatically decreased with maternal antiretroviral therapy, breast milk transmission accounts for most of the 180 000 new infant HIV infections annually. Broadly neutralizing antibodies (bNAb) may further reduc...
保存先:
| 出版年: | J Infect Dis |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7377284/ https://ncbi.nlm.nih.gov/pubmed/31681963 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiz532 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|